Great news (RMW) Phase II Prostate Cancer Trial is being presented today, discussing the results of the PhotosoftTM technology
(RMW) Phase II Prostate Cancer Trial is being presented today, to view the Poster on the trials go to the Invion Ltd investor hub! (inviongroup.com)
Invion Limited (ASX: IVX) (“Invion” or the “Company”) understands that a poster presentation of preliminary results from RMW Cho Group Limited’s (RMW) Phase II Prostate Cancer Trial is being presented today at the Australian and New Zealand Urogenital and Prostate (ANZUP) Annual Scientific Meeting 2023.
RMW is the patent holder and licensor of the PhotosoftTM technology. Invion is not involved with the presentation or the trial, but in the interest of full disclosure, the poster is attached to this announcement. Further, as these are preliminary results, investors may not be in a position to form conclusions related to the trial from the poster presentation.
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)